Filing Details
- Accession Number:
- 0001181431-10-017485
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-19 13:00:00
- Reporting Period:
- 2010-03-17
- Filing Date:
- 2010-03-19
- Accepted Time:
- 2010-03-19 19:00:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1382911 | Orexigen Therapeutics Inc. | OREX | Pharmaceutical Preparations (2834) | 651178822 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1202793 | Michael Powell | C/O Sofinnova Ventures, Inc. 140 Geary Street 10Th Floor San Francisco CA 94108 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-03-17 | 125,431 | $6.29 | 1,509,624 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2010-03-18 | 278,917 | $6.15 | 1,230,707 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2010-03-19 | 173,292 | $6.00 | 1,057,415 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2010-03-17 | 24,867 | $6.29 | 299,077 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2010-03-18 | 55,297 | $6.15 | 243,780 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2010-03-19 | 34,356 | $6.00 | 209,424 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2010-03-17 | 1,702 | $6.29 | 20,553 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2010-03-18 | 3,786 | $6.15 | 16,767 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2010-03-19 | 2,352 | $6.00 | 14,415 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1 | Direct |
Footnotes
- Shares are held by Sofinnova Venture Partners VI, L.P. ("SV VI"). Sofinnova Management VI, L.L.C. ("SV VI LLC"), the general partner of SV VI, and Michael Powell, a director of the issuer, James I. Healy, Alain L. Azan and Eric P. Buatois, the managing members of SV VI LLC, may be deemed to share voting and dispositive power over the shares held by SV VI. Such persons and entities disclaim beneficial ownership of shares held by SV VI except to the extent of any pecuniary interest therein.
- Shares are held by Sofinnova Venture Partners VI GmbH & Co. KG. ("SV VI KG"). Sofinnova Management VI, L.L.C. ("SV VI LLC"), the managing limited partner of SV VI KG, and Michael Powell, a director of the issuer, James I. Healy, Alain L. Azan and Eric P. Buatois, the managing members of SV VI LLC, may be deemed to share voting and dispositive power over the shares held by SV VI KG. Such persons and entities disclaim beneficial ownership of shares held by SV VI KG except to the extent of any pecuniary interest therein.
- Shares are held by Sofinnova Venture Affiliates VI, L.P. ("SV VI Affiliates"). Sofinnova Management VI, L.L.C. ("SV VI LLC"), the general partner of SV VI Affiliates, and Michael Powell, a director of the issuer, James I. Healy, Alain L. Azan and Eric P. Buatois, the managing members of SV VI LLC, may be deemed to share voting and dispositive power over the shares held by SV VI Affiliates. Such persons and entities disclaim beneficial ownership of shares held by SV VI Affiliates except to the extent of any pecuniary interest therein.